Regulated Information

Filter

Period

Filter by

recent search

Showing: 1 – 05 of 114 Regulated Information

Ipsen updates on QM-1114 regulatory process
Ipsen updates on QM-1114 regulatory process

PARIS, FRANCE, 3 October 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its partner Galderma has confirmed receipt from the FDA of a Complete Response Letter related to its Biologics License Application for liquid botulinum toxin type A…


IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 37 – 2023

Aggregated presentation by day and by market


IPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2023

Aggregated presentation by day and by market


Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rightsand shares composing the share capital


1 2 3 4 5 6 23